Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Obstructed Megaureter : Article by

Quick Find
Authors & Editors
Introduction
Indications
RELEVANT ANATOMY
Contraindications
Workup
Treatment
Complications
Outcome And Prognosis
Future And Controversies
Multimedia
References




Patient Education
Click here for patient education.



Author: Robert A Mevorach, MD, Associate Professor, Departments of Urology and Pediatrics, University of Rochester School of Medicine

Robert A Mevorach is a member of the following medical societies: American Academy of Pediatrics and American Urological Association

Editors: Bradley Fields Schwartz, DO, FACS, Associate Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center; Stephen W Leslie, MD, FACS, Founder and Medical Director of the Lorain Kidney Stone Research Center, Clinical Assistant Professor, Department of Urology, Medical College of Ohio

Author and Editor Disclosure

Synonyms and related keywords: primary obstructed megaureter, primary obstructing megaureter, secondary obstructing megaureter, refluxing nonobstructing megaureter, nonrefluxing obstructing megaureter, congenital megaureter, megaloureter, antenatal hydroureteronephrosis, obstructive megaureter, dilated ureter, abnormal ureteral musculature, ureterocele, ectopic insertion, hydronephrosis, prenatal hydronephrosis, hematuria, azotemia, urinary tract infection, UTI, hydroureter, sepsis



In 1923, Caulk described a patient with distal ureteral dilatation without evidence of hydronephrosis and coined the term megaloureter. Thirty years later, Swenson postulated a neurologic etiology for both megacolon and megaureter and treated patients with urinary diversion, ureteral substitution, and ileal augmentation to provide peristalsis. Clinical management of megaureter evolved over the next 2 decades. Stephens, Nesbitt, and Withycombe advised observation and double voiding to reduce the incidence of urinary tract infections (UTIs); they admonished those who practiced the surgical approaches of the period.

History of the Procedure

Johnston, Hendren and Henderson, and Creevy advanced the field of surgical management of megaureter through aggressive ureteral tailoring and the adaptation of experience in ureteral reimplantation for vesicoureteral reflux.1, 2 Williams and Hulme-Moir launched the era of modern care of the primary megaureter by demonstrating a spectrum of this disorder that could be managed with observation in less-severe cases, with excellent clinical and radiographic outcomes.3

Obstructive megaureter is, in itself, a misnomer because most cases demonstrate partial obstruction. Although this entity is rare, the principles of its evaluation and management may apply to a wide spectrum of ureteral abnormalities; consequently, a thorough understanding has a wide application.

Problem

Megaureter, the accepted term for the dilated ureter, is divided into primary (congenital) and secondary categories. Each category is further subdivided into (1) refluxing nonobstructing megaureter and (2) nonrefluxing obstructing megaureter. These distinctions are based on radiographic and clinical findings. This article discusses primary obstructive megaureter.

Frequency

The incidence is 1 per 10,000 population. The male-to-female ratio is 1.2-4.8:1. The left-to-right ratio is 1.7-4.5:1. Obstruction is bilateral in 10-20% of cases.

Etiology

Primary obstructing megaureter is caused by a structural alteration in the muscular layers of the distal ureter, which is characterized, to varying degrees, by diminished or absent longitudinal muscle fibers, hypertrophied or hyperplastic circular muscle fibers, or increased connective tissue deposition. These changes are defined pathologically and may represent either an arrest of normal development or an intrauterine response of the ureter to ongoing obstruction.

Animal models of congenital megaureter are lacking, but Mortell et al have developed a rat model of prenatal doxorubicin (Adriamycin) exposure that may help elucidate the etiology of this developmental defect.4

Pathophysiology

Partial obstruction in the abnormal distal segment of the ureter leads to progressive dilatation. Progression to hydronephrosis (ie, dilation of the renal pelvis and calyces) occurs when the ureter no longer accommodates resistance to urinary drainage; pressure is then conveyed more proximally. Complete obstructions are rare and are invariably associated with a nonfunctioning renal unit at diagnosis.

Primary obstructed megaureters enter the bladder in a normal location on the trigone, with the ureteral orifice appearing unaffected. This entity should not be confused with ectopic megaureters that end in an abnormal location within the lower urinary tract or other mesonephric anlage.

Clinical

Children with an obstructed megaureter may present with vague abdominal pain, hematuria, UTI, fever of unknown origin, or an abdominal mass. The primary presentation, antenatal hydronephrosis, is diagnosed with prenatal ultrasonography.

Prenatal ultrasonography reveals an indication of an underlying genitourinary abnormality in as many as 1 per 100 births; most of these are hydronephroses. Clinical presentation of primary megaureter, which is less common since the advent of fetal ultrasonography, includes the following:

  • UTI
  • Hematuria
  • Pyuria
  • Flank mass
  • Failure to thrive
  • Sepsis
  • Fever of unknown origin
  • Abdominal or pelvic pain
  • Abdominal mass
  • Urolithiasis
  • Serendipitous identification on imaging (eg, ultrasonography ; CT scanning; kidneys, ureters, and bladder [KUB] radiography; bone scan)



The diagnosis is established radiographically based on definition of a dilated distal ureteral segment that inserts into a normal ureteral meatus. Findings on endoscopy reveal that these ureteral tunnels are not obstructed to retrograde passage of a ureteral catheter or probe. However, when viewed fluoroscopically, the peristalsis of the ureter, which halts abruptly at the narrowing, can be observed. Associated abnormalities may include the following:

  • Contralateral renal agenesis (9-15%)
  • Microcystis in bilateral lesions
  • Contralateral ureteroceles
  • Renal dysplasia
  • Ureteral duplication

Increasing ureteral dilation warrants consideration of renal and ureteral drainage. Megaureters detected in neonates and infants may require drainage for infections that do not respond to antibiotics alone. Additionally, the massively dilated ureter may be decompressed with ureterostomy, pyelostomy, or nephrostomy drainage, which often allows a substantial decrease in ureteral size and greatly reduces ureteral bulk during both tailoring and reimplantation.



Congenital and acquired lesions that cause obstruction of the distal ureter have been reported, and, in certain instances, these lesions confound the diagnosis. While a primary obstructed megaureter may subtend both the single and the duplicated collecting systems, it is associated most commonly with a single system.

  • Ureteroceles are more common in females and are associated with the upper-pole ureter of a complete duplication of the renal collecting system. Protrusion of the dilated distal ureter within the bladder or urethral lumen defines this lesion.
  • Ureteral valves, membranes, and polyps demonstrate intrinsic filling defects that differentiate these lesions from primary megaureter. These lesions are rare.
  • Ureteral calculi may become impacted in the distal ureter and may be associated with scarring. The resultant ureteral narrowing may obscure the underlying diagnosis; however, management principles are consistent, regardless of the underlying pathology.



In mild cases, surgery may be unnecessary. Physicians may monitor symptoms, perform periodic radiologic imaging, and administer antibiotic prophylaxis.

Document that patients are free of infection at the time of reconstruction.



Lab Studies

  • Sequential Multiple Analysis–6 different serum tests
    • Sequential Multiple Analysis–6 different serum tests (SMA-6) includes measurement of creatinine and BUN to assess gross renal function.
    • Levels of sodium, potassium, chloride, or bicarbonate may show subtle changes in some patients with bilaterality or associated dysplasia.
    • In neonates, wait 3-5 days to evaluate the infant's kidney function rather than the mother's kidney function.
    • A creatinine level of 1 mg/dL or greater at age 1 year is prognostic for subsequent renal failure.
  • A serum calcium assessment for associated ureteral calculi is an essential screening test for hyperparathyroidism.
  • Urinalysis is recommended upon evidence of infection, proteinuria, high pH level, and low specific gravity that may reflect underlying infection or renal dysplasia or damage.
    • Screen for UTI.
    • Assess urine concentration and acidification in bilateral lesions and dysplasia.

Imaging Studies

  • Renal or bladder ultrasonography
    • Prenatal imaging reveals both hydroureter and hydronephrosis. Repeat ultrasonography for hydronephrosis within the first few days of life in patients with solitary kidney or bilateral lesions. Hydroureter and unilateral lesions may be evaluated electively within the first 2 months of life.
    • Postnatal imaging is used to define the degree of hydronephrosis based on the following Society of Fetal Urology guidelines:
      • Grade I - Splitting of the renal sinus more than 10 mm
      • Grade II - Splitting of the renal sinus more than 10 mm in an extrarenal or intrarenal pelvis not extending to the calyces
      • Grade III - Dilatation extending into the calyces without cortical thinning
      • Grade IV - Dilatation extending into the calyces with cortical thinning
    • Postnatal imaging further defines the following anatomy:
      • Extent of hydroureter, presence of collecting system duplication
      • Presence or absence of ureterocele
      • Bladder configuration, size, and thickening
    • Postnatal imaging further provides clinically relevant data, including the following:
      • Presence or absence of calculi
      • Echogenic debris suggesting infection
      • Indirect evidence of degree of obstruction by presence of a ureteral jet
      • Location and condition of remaining renal units
  • Voiding cystourethrography (VCUG) is performed to assess for the presence of vesicoureteral reflux and to further delineate the anatomy of the bladder and outlet. In boys with bilateral megaureter, posterior urethral valves must be excluded.
  • Radionuclide renal scanning
    • After ultrasonography and VCUG are performed, the diagnosis of primary megaureter may be secure; the only remaining clinical issue is evaluating for obstruction. In these cases, technetium Tc 99m diethylenetriamine pentaacetic acid (DTPA) or technetium Tc 99m mercaptotriglycylglycine (MAG-3) renal scanning may be used to assess renal blood flow, relative function, and drainage.  It is also helpful in predicting the capacity for functional recovery prior to surgery.
    • Increasing ureteral dilation warrants consideration of renal and ureteral drainage. Although kidney drainage may be normal, it may be the result of urine pooling in the abnormally dilated ureter, resulting in ureteral obstruction.
    • Exact definitions of obstruction do not exist. Serial examinations to demonstrate a trend toward decreasing function or delayed drainage are often required to establish an accurate treatment approach. In addition, renal resistive index can be used to help identify true obstruction as long as renal function is good.
  • Intravenous urography: In cases in which anatomic definition is desired, intravenous urography (IVU) can be used if renal function is good and the degree of obstruction to the affected renal unit is mild.
  • Magnetic resonance imaging: In centers that have the technology, MRI can be used to reconstruct a 3-dimensional depiction of the urinary collecting system. The requirement for special software to assess renal function accurately and the need for restraint, sedation, or general anesthesia limit its application in neonates and infants.

Diagnostic Procedures

  • Antegrade pyelography
    • Antegrade injection of contrast directly into the renal pelvis via percutaneous access is used as an adjunct to placement of a nephrostomy tube to drain an infected system or to define an equivocal obstruction (Whitaker test) by infusion of contrast medium at a fixed rate with concurrent pressure measurements in the kidney and bladder. Infusion rates for adults generally have been 10 mL per minute, and a pressure differential between kidney and bladder of less than 15 cm H2O is accepted as normal. This study is often used to provide additional evidence of obstruction to support surgical intervention. This technique also helps to delineate anatomy when diagnostic questions persist after less-invasive testing, often in the same setting as planned surgical repair.
    • As is evident from the 600-mL/h rate of urine flow that is used in the Whitaker test, the physiologic implications of all except negative test results are debatable. In the author's experience, this test is too dependent on variations in anatomy (renal collecting system compliance) and technique to provide any real benefit over a gestalt from antegrade pyelography alone.
  • Retrograde pyelography: Placement of a catheter into the ureteral meatus via endoscopy with injection of contrast medium under real-time fluoroscopy is reserved for diagnostic dilemmas and as an adjunct to surgery.

Histologic Findings

Surgical pathology reveals 5 histologic types: (1) abnormal circular orientation of muscle fibers with hypertrophy and hyperplasia, (2) mural fibrosis with little normal muscle within the ureteral wall, (3) hypoplasia and atrophy of all ureteral musculature, (4) absent longitudinal musculature, and (5) normal ureteral anatomy.



Medical therapy

In mild cases, physicians may monitor symptoms, perform periodic radiological imaging, and administer antibiotic prophylaxis. With improving or stable renal or ureteral dilatation and continued renal growth, prognosis (over 8 y of follow-up) is excellent.

  • Antibiotics
    • Amoxicillin
    • Penicillin
    • Cephalexin (for patients <3 mo)
    • Sulfamethoxazole
    • Sulfamethoxazole-trimethoprim (SMZ-TMP)
    • Nitrofurantoin (for patients >3 mo)

Surgical therapy

Megaureters detected in neonates and infants may require drainage for infections that do not respond to antibiotics alone. Additionally, the massively dilated ureter may be decompressed with ureterostomy, refluxing ureteroneocystostomy, pyelostomy, or nephrostomy drainage, which often allows a substantial decrease in ureteral size and greatly reduces ureteral bulk during both tailoring and reimplantation.

The ultimate goals of surgical intervention are to relieve obstruction, return near-normal function to the collecting system, create a nonrefluxing vesicoureteral reimplantation, and preserve renal development without long-term complications. With these goals, the two main surgical approaches are as follows:

  • Distal ureteral mobilization with resection of the obstructing segment and reimplantation, with or without ureteral tailoring (to ensure a nonrefluxing tunnel)
  • Extensive tailoring of the ureter from the renal pelvis distally to provide a theoretical benefit for restoring normal peristalsis by reduction of ureteral luminal diameter

In experienced hands, both approaches yield excellent long-term results. Substantive differences are not statistically or clinically apparent.

Patients with voiding dysfunction or significant reflux may benefit from an intravesical ureteral reimplantation. Patients without voiding problems or reflux do equally well from an extravesical approach.

Primary endoureterotomy with stenting has been reported favorably in selected cases in children. In one series, 90% of cases showed improvement with complete resolution reported in 71%.5

In adults, a direct nipple ureteroneocystostomy can be performed. This is technically simpler to perform since the ureters and submucosal tunnels require no tailoring. Limited reports with follow-up of up to 36 months indicate a high success rate with this technique in adults.6

Preoperative details

Document that patients are free of infection at the time of reconstruction. Blood loss normally is not substantial, and transfusion is rare.

Intraoperative details

The incision is chosen to access the upper ureter, the lower ureter, or the entire ureter. Use intravesical and extravesical dissection, alone or in combination, to mobilize the enlarged ureter.

Take care to preserve the ureteral blood supply, which arises from the aorta, renal artery, gonadal artery, and internal iliac artery, particularly if undertaking extensive tailoring.

Tailoring either can be excisional or can involve varied forms of luminal exclusion and ureteral folding; however, reductions smaller than 10F are not recommended to avoid subsequent stenosis.

Neocystostomy tunnel lengths of 4:1-6:1 are recommended to avert postoperative reflux. Postoperative drains or splints for the ureters are used at the discretion of the surgeon.

Postoperative details

Patients remain on antibiotic prophylaxis for months after surgery, until imaging studies or clinical status warrants discontinuation.

Follow-up

Repeated ultrasonography imaging is mandatory to assess whether hydronephrosis and hydroureter improve after surgery. Because the benefit of repeat VCUG and IVU studies is controversial, in the setting of clinical success and ultrasonography improvement, the only recommendation is that the patient and physician agree on the follow-up regimen.



Surgical complications are uncommon and often resolve with observation.

  • Ipsilateral reflux occurs in 2% of patients. Endoscopic ureteral bulking permits a less-invasive management of this complication when the clinical scenario warrants, and it may all but eliminate open reoperation.
  • Contralateral reflux occurs in 10% of patients but resolves within 1 year in nearly all cases.
  • Ureteral obstruction (1%): Early balloon dilatation or incision of the meatal stenosis (3 mo) is highly successful. Strongly consider ureteral stenosis of 1.5 cm or greater and devascularized ureteral segments for open reoperation.
  • Incomplete bladder emptying requiring catheterization (5%): Permanent retention is not reported.



Researchers report that surgical outcomes are 98% successful in all major series. Failures were usually in the form of reflux and often occurred with nontapered reimplants. Reoperation with tailoring and repeat neocystostomy is uniformly corrective.

Children who present with infection may experience persistent episodes of UTI. Consider these patients for prolonged prophylaxis to limit the impact of infection on renal growth. Additionally, emphasize UTI surveillance during pregnancy.

Renal function is the key determinant of prognosis because renal dysplasia and infection with associated renal insufficiency are the only expected long-term disabilities associated with primary obstructed megaureter.



As with all reconstructive procedures, the belief that recapitulation of anatomy is necessary to achieve excellent functional results is tested continually by the desire to minimize the extent and duration of surgical invasion. When patients are well-served, finding fault with either approach is difficult.

The next wave of interest will arise from the growing trend toward minimally invasive surgery and the application of improved laparoscopic and robotic techniques to reconstructive pediatric urology.



Media file 1:  This renal sonogram demonstrates hydronephrosis with good parenchymal thickness and retained corticomedullary differentiation.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 2:  This pelvic sonogram reveals the classic spindle configuration of primary obstructed megaureter.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 3:  This panel from a technetium Tc 99m mercaptotriglycylglycine (MAG-3) renal scan shows differential obstruction of each kidney. While the classic image of a primary obstructed megaureter is shown on the left, a severe congenital ureteropelvic junction obstruction is present in the contralateral kidney. (These images are viewed with the left kidney on the left portion of each panel and the right kidney on the right portion of each panel.)
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image



  1. Hendren WH, Henderson BM. Recent advances in pediatric surgery. Am J Surg. Sep 1969;118(3):338-55. [Medline].
  2. Creevy CD. The atonic distal ureteral segment (ureteral achalasia). J Urol. Mar 1967;97(3):457-63. [Medline].
  3. Williams DI, Hulme-Moir I. Primary obstructive mega-ureter. Br J Urol. Apr 1970;42(2):140-9. [Medline].
  4. Mortell A, Fourcade L, Solari V, Puri P. Bilateral megaureters in the Adriamycin rat model. Pediatr Surg Int. Mar 2005;21(3):212-6. [Medline].
  5. Kajbafzadeh AM, Payabvash S, Salmasi AH, Arshadi H, Hashemi SM, Arabian S, et al. Endoureterotomy for treatment of primary obstructive megaureter in children. J Endourol. Jul 2007;21(7):743-9. [Medline].
  6. Tatlisen A, Ekmekçioglu O. Direct nipple ureteroneocystostomy in adults with primary obstructed megaureter. J Urol. Mar 2005;173(3):877-80. [Medline].
  7. Arena F, Baldari S, Proietto F, Centorrino A, Scalfari G, Romeo G. Conservative treatment in primary neonatal megaureter. Eur J Pediatr Surg. Dec 1998;8(6):347-51. [Medline].
  8. Bakker HH, Scholtmeijer RJ, Klopper PJ. Comparison of 2 different tapering techniques in megaureters. J Urol. Nov 1988;140(5 Pt 2):1237-9. [Medline].
  9. Bapat S, Bapat M, Kirpekar D. Endoureterotomy for congenital primary obstructive megaureter: preliminary report. J Endourol. Apr 2000;14(3):263-7. [Medline].
  10. Belman AB. Megaureter. Classification, etiology, and management. Urol Clin North Am. Oct 1974;1(3):497-513. [Medline].
  11. DeFoor W, Minevich E, Reddy P, Polsky E, McGregor A, Wacksman J, et al. Results of tapered ureteral reimplantation for primary megaureter: extravesical versus intravesical approach. J Urol. Oct 2004;172(4 Pt 2):1640-3; discussion 1643. [Medline].
  12. Erbas B, Royal SA, Joseph D. Scintigraphic evaluation of obstructing primary megaureter with Tc-99m MAG3. Clin Nucl Med. Jun 1997;22(6):355-8. [Medline].
  13. Lee SD, Akbal C, Kaefer M. Refluxing ureteral reimplant as temporary treatment of obstructive megaureter in neonate and infant. J Urol. Apr 2005;173(4):1357-60; discussion 1360. [Medline].
  14. Lockhart JL, Politano VA. Management of massively dilated ureters in children. Urology. Sep 1981;18(3):229-34. [Medline].
  15. McLaughlin AP 3rd, Pfister RC, Leadbetter WF, Salzstein SL, Kessler WO. The pathophysiology of primary megaloureter. J Urol. May 1973;109(5):805-11. [Medline].
  16. Patti G, Menghini ML, Todini AR, Marrocco G, Calisti A. The role of the renal resistive index ratio in diagnosing obstruction and in the follow-up of children with unilateral hydronephrosis. BJU Int. Feb 2000;85(3):308-12. [Medline].
  17. Payabvash S, Kajbafzadeh AM, Tavangar SM, Monajemzadeh M, Sadeghi Z. Myocyte apoptosis in primary obstructive megaureters: the role of decreased vascular and neural supply. J Urol. Jul 2007;178(1):259-64; discussion 264. [Medline].
  18. Rabinowitz R, Barkin M, Schillinger JF, Jeffs RD. Surgical treatment of the massively dilated primary megaureter in children. Br J Urol. Feb 1979;51(1):19-23. [Medline].
  19. Rabinowitz R, Barkin M, Schillinger JF, Jeffs RD, Cook GT. Surgical treatment of the massively dilated ureter in children. Part II. Management by primary reconstruction. J Urol. Sep 1977;118(3):436-9. [Medline].
  20. Rabinowitz R, Barkin M, Schillinger JF, Jeffs RD, Cook GT. The influence of etiology on the surgical management and prognosis of the massively dilated ureter in children. J Urol. Jun 1978;119(6):808-13. [Medline].
  21. Shukla AR, Cooper J, Patel RP, Carr MC, Canning DA, Zderic SA, et al. Prenatally detected primary megaureter: a role for extended followup. J Urol. Apr 2005;173(4):1353-6. [Medline].
  22. Stehr M, Metzger R, Schuster T, Porn U, Dietz HG. Management of the primary obstructed megaureter (POM) and indication for operative treatment. Eur J Pediatr Surg. Feb 2002;12(1):32-7. [Medline].
  23. Tanagho EA. Embryologic basis for lower ureteral anomalies: a hypothesis. Urology. May 1976;7(5):451-64. [Medline].
  24. Thompson A, Gough DC. The use of renal scintigraphy in assessing the potential for recovery in the obstructed renal tract in children. BJU Int. Jun 2001;87(9):853-6. [Medline].

Obstructed Megaureter excerpt

Article Last Updated: Sep 27, 2007